-
Alectinib (CAS: 1256580-46-7)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Alectinib NSCLC Roche Pharma AG Jun. 9,2030 -
Aprocitentan (CAS: 1103522-45-7)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Aprocitentan hypertension Idorsia Pharmaceuticals Deutschland GmbH Sep. 21.2034 -
Abemaciclib
API’s Name Indication Innovator Patent Expiry Date(The U.S) Abemaciclib Breast cancer, prostate cancer treatment Eli Lily Dec.15,2029 -
Apremilast
API’s Name Indication Innovator Patent Expiry Date(The U.S) Apremilast psoriatic arthritis Celgene -
Abrocitinib
API’s Name Indication Innovator Patent Expiry Date(The U.S) Abrocitinib Atopic Dermatitis Pfizer Feb.11, 2034 -
Agomelatine
API’s Name Indication Specification US DMF EU DMF CEP Agomelatine Depression In-House √ -
Atorvastatin Calcium
API’s Name Indication Specification US DMF EU DMF CEP Atorvastatin Calcium Hypercholesterolemia In-House/CEP 29057 √ CEP 2015-034